Acorda Therapeutics initiated at CitiACOR coverage initiated with a $39 price target and Hold rating. No M&A soon, Citigroup said. 2010 and 2011 EPS estimates set at -$1.49 and $0.12, respectively.
Amylin Pharma initiated at Piper JaffrayAMLN initiated at Piper Jaffray. Initiated with a Neutral rating and $26 price target. Introduces 2010 EPS estimates of -$0.11.
Airgas downgraded at William BlairARG was downgraded to Market Perform, William Blair said. Valuation call. Estimates also lowered, as the company is facing higher costs.
Biovail initiated at BofA/MerrillBVF initiated at Bank of America/Merrill Lynch with a Buy rating and $21 price target. Compelling risk-reward.
Continental Resources upgraded at Morgan KeeganCLR was upgraded from Market Perform to Outperform, Morgan Keegan said. Company has a rapidly accelerating program in the Bakken shale.
Rockwell Collins downgraded at GoldmanCOL was downgraded from Buy to Neutral, Goldman Sachs said. $72 price target. Stock is up 80% over the past 12 months.
Dresser-Rand downgraded at GoldmanDRC was downgraded from Neutral to Sell, Goldman Sachs said. Estimates also lowered, as the company has late-cycle leverage.
Global Partners upgraded at BofA/MerrillGLP upgraded to Buy from Neutral. Offering clears deck to play offense, Bank of America/Merrill Lynch said. $26.50 price target.
Ingram Micro initiated at BarclaysIM coverage initiated with an Equal Weight rating and $20 price target. 2010 and 2011 EPS estimates set at $1.70 and $1.95, respectively. Should benefit from improving IT spending, Barclays said.
Kellogg downgraded at BMORating on K was lowered to Market Perform, BMO Capital Markets said. Valuation call, as cereal sales could slow. $59 price target.
Lincare downgraded at DeutscheLNCR was downgraded from Buy to Hold, Deutsche Bank said. $47 price target. Valuation call, as the stock is already pricing in above-average growth.
Lorillard downgraded at DeutscheLO was downgraded from Buy to Hold, Deutsche Bank said. $83 price target. Company is facing higher regulatory risk.
O'Reilly Automotive downgraded at JP MorganORLY downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Maintains $44 price target and 2010 EPS estimates of $2.54.
Precision Castparts upgraded at GoldmanPCP was upgraded from Neutral to Buy, Goldman Sachs said. $153 price target. Company is leveraged to higher aerospace production rates.
POWI was downgraded from Buy to Hold, Deutsche Bank said. Stock has traded through the $40 price target, though near-term trends remain strong.
Patterson-UTI upgraded at GoldmanPTEN was upgraded from Sell to Neutral, Goldman Sachs said. Stock should bottom along with natural gas prices. $51 price target.
Synovus downgraded at FBRSNV was downgraded from Market Perform to Underperform, FBR Capital Markets said. Valuation call, based on a $2.50 price target.
Solarfun Power upgraded at BarclaysSOLF upgraded to Equal Weight from Underweight on improving OEM business model, Barclays said. Price target doubled to $8 from $4. 2010 and 2011 EPS estimates boosted to 80 cents and 62 cents, respectively.
Syniverse upgraded at JefferiesSVR was upgraded from Hold to Buy, Jefferies said. $22 price target. Company is leveraged to an economic recovery and higher data traffic.
Southwestern Energy upgraded at GoldmanSWN was upgraded from Neutral to Buy, Goldman Sachs said. Stock also added to the Conviction List, with a $54 price target. Company can post superior growth in natural gas.
Molson Coors downgraded at DeutscheTAP was downgraded from Buy to Hold, Deutsche Bank said. $47 price target. Company will likely be hurt by weaker domestic volumes.
TECD initiated at Barclays with an Equal Weight rating and $47 price target. TECD should benefit from more IT spending. 2011 and 2012 EPS estimates set at $3.70 and $4.10, respectively.
Theravance initiated at Piper JaffrayTHRX initiated at Piper Jaffray. Initiated with an Overweight rating and $16 price target. Introduces 2010 EPS estimates of -$0.85.
Timken upgraded at LongbowTKR was upgraded from Neutral to Buy, Longbow Research said. $36 price target. Company should benefit from a better steel and bearings outlook.
Viacom upgraded at Morgan StanleyVIA.B was upgraded from Underweight to Equal-weight, Morgan Stanley said. $37 price target. Aggressive cost-cutting should help earnings. Equal-weight rating.
Verisign downgraded at JefferiesVRSN was downgraded from Buy to Hold, Jefferies said. $27 price target. Valuation call, as the company has limited pricing power in its business.
Atheros Communications numbers raised at FBRShares of ATHR now seen reaching $41, according to FBR Capital Markets. Estimates also boosted, as the company is likely seeing strong sales momentum. Market Perform rating.
Bed Bath & Beyond target, estimates boosted at BofA/MerrillBBBY price target increased to $50 from $44 on broad-based improvement in home related goods so far in 2010, Bank of America/Merrill Lynch said. 2010 and 2011 EPS estimates set at $2.22 and $2.52, respectively.
Burger King price target higher at CitiBKC price target raised to $22 from $19 as recent sales figures show improvement, Citigroup said. 2010 and 2011 EPS estimates held at $1.35 and $1.54, respectively.
Burger King estimates, target raised at GoldmanBKC estimates were increased through 2012, Goldman Sachs sai. Company is improving its brand image and breakfast should help drive growth. Neutral rating and new $22 price target.
Brookdale Senior cut from Conviction Buy list at GoldmanBKD was removed from the Conviction Buy List, Goldman Sachs said. Stock has limited upside potential, based on a $22 price target.
CSX Corp target and estimates raised at BofA/MerrillCSX price target jumped to $58 from $55 on higher volumes, Bank of America/Merrill Lynch said. 2010 and 2011 EPS estimates lifted to $3.35 and $3.80, respectively. Maintain buy rating.
Dreamworks Animation numbers lowered at GoldmanShares of DWA now seen reaching $49, according to Goldman Sachs. Estimates also cut, given a lower opening for "How to Train Your Dragon". Buy rating.
CarMax estimates raised at Credit SuisseKMX 2010 and 2011 EPS estimates increased to $1.17 and $1.21, respectively. Maintain Neutral rating and $23 price target.
NY Community Bancorp estimates upped at Morgan StanleyNYB estimates were increased through 2011, Morgan Stanley said. FDIC-assisted acquisition should have a small benefit to earnings. Equal-weight and $17 price target.
Silicon Laboratories estimates upped at FBRSLAB estimates were increased through 2011, FBR Capital Markets said. Recent checks suggest robust business trends. Outperform rating and $61 price target.
Zions Bancorp estimates, target increased at FBRShares of ZION now seen reaching $24, according to FBR Capital Markets. Estimates also boosted, as the company should benefit from improving credit costs. Outperform rating.
